We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Bend Research Announces a New cGMP Spray-Drying Facility
News

Bend Research Announces a New cGMP Spray-Drying Facility

Bend Research Announces a New cGMP Spray-Drying Facility
News

Bend Research Announces a New cGMP Spray-Drying Facility

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Bend Research Announces a New cGMP Spray-Drying Facility"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Bend Research Inc. has announced the addition of a new current Good Manufacturing Practice (cGMP) spray-drying facility.

The new facility expands Bend Research’s capabilities and expertise in the area of development and manufacture of high-potency drug candidates.

The company’s new facility is well-suited for the manufacture of a wide range of compound types and safety classifications, ranging from inhalable biotherapeutics to oral solid form high-potency small molecules.

The facility is physically separated from the company’s other development and cGMP manufacturing facilities and is designed for high containment operations at the highest safety and quality standards, utilizing the latest best-practice design features, finishes and engineering controls at the equipment level.

“We’re excited to offer our clients expanded cGMP spray-drying capability for high-potency compounds,” said Rod Ray, Chief Executive Officer. “This facility will complement our small molecule cGMP spray drying capabilities.”

The new facility is only part of the Bend Research’s expansion plans as the company enters its next phase of strategic growth.

In addition to the new high-potency spray-drying facility, the company recently expanded its solid-dosage-form capability and purchased an additional building for future expansion of development and manufacturing capabilities.

Advertisement